Abstract:Between 1992 and 1997, 790 blood donors with anti-HCV EIA-2 strongly reagent (relationship between the sample optical density/cut-off > 3) detected at the blood bank serological screening, were evaluated in ambulatory environment. They were all negative for Chagas disease, syphilis, hepatitis B (HBsAg) and AIDS. Blood samples were collected at the first ambulatorial evaluation, for hemogram, biochemical tests and new serological tests for HCV (anti-HCV EIA-2). In blood samples of 226 repeatedly reagent anti-HCV EIA-2 blood donors, supplementary "immunoblot" test for HCV (RIBA-2) was used. In 209 donors, the presence of HCV-RNA was investigated by the PCR test. The abdominal ultrasonography was realized in 366 donors. In 269 patients liver biopsy was performed for the histopathological study. The follow-up of blood donors showed that 95.6% were repeatedly EIA-2 reagent, 94% were symptomless and denied any hepatitis history, with only 2% mentioning previous jaundice. In 47% of this population at least one risk factor has been detected for the HCV transmission, the use of intravenous drugs being the main one (27.8%). Blood transfusion was the second factor for HCV transmission (27.2%). Hepatomegaly was detected in 54% of the cases. Splenomegaly and signs of portal hypertension have seldom been found in the physical examination, indicating a low degree of hepatic compromising in HCV. Abdominal ultrasound showed alterations in 65% of the subjects, being the steatosis the most frequent (50%). In 83. 5% of the donors submitted to the liver biopsy, the histopathological exam showed the presence of chronic hepatitis, usually classified as active (89%) with mild or moderate grade in most of the cases (99.5%). The histopathological exam of the liver was normal in 1.5% of blood donors. The RIBA-2 test and the HCV-RNA investigation by PCR were positive in respectively 91.6 and 75% of the anti-HCV EIA-2 reagent donors. The HCV-RNA research was positive in 82% of the RIBA-2 positive subjects, in 37.5% of the indeterminate RIBA-2 donors and in 9% of the negative RIBA-2 donors. Chronic hepatitis has also been observed in 50% of the histopathological exams of the anti-HCV EIA-2 reagent donors which were indeterminate RIBA-2. Among 18 blood donors with minimal changes histopathological exam 11 (61%) were HCV-RNA positive. Our blood donors anti-HCV reagent generally had clinical, laboratorial and histopathological features observed in patients with chronic HCV hepatitis and a high proportion could be identified in interviews and medical evaluation realized in blood blanks. Generally, these HCV infected donors are identified and discharged only by the serological tests results.

HIV Antibody Screening and Confirmatory Testing of Italian Blood Donors

Comparison between screening and confirmatory serological assays in blood donors in a region of South Italy

The importance of confirmatory assays in testing blood donors for human T‐cell lymphotropic virus

Serologic screening for viral infections among blood donors: a study in a blood bank in southern Brazil

Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.

Italian blood donors with anti-HBc and occult hepatitis B virus infection

A clinical, epidemological, laboratorial, histological and ultrasonographical evaluation of anti-HCV EIA-2 positive blood donors

Serological and Molecular Characterization of Occult HBV Infection in Blood Donors from South Italy

Parallel Enzyme-Linked Immunosorbent Assay Screening for Human Immunodeficiency Virus among Blood Donors in Five Chinese Blood Centres: A Retrospective Analysis

IMPORTANCE OF WESTERN BLOT ANALYSIS IN PREDICTING INFECTIVITY OF ANTI-HTLV-III/LAV POSITIVE BLOOD

[SHTLV-I/II seroprevalence in blood donors of Hospital Pablo Tobón Uribe Blood Bank during the period 2014-2015]

Comparative evaluation of ELISA & CLIA screening assays in the effective detection of HIV infection in blood donor samples

Correlation of serological and molecular markers in the screening for hepatitis B virus in blood bank in northern Brazil

Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection

Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review

Evidence of acute primary occult hepatitis B virus infection in an Italian repeat blood donor

Prevalence, incidence, risk factors and residual risk associated with viral infections among eligible Brazilian blood donors

High rate of hepatitis C virus and human immunodeficiency virus false-positive results in serologic screening in sub-Saharan Africa: adverse impact on the blood supply

Seroprevalence of human immunodeficiency virus in African blood donors: a systematic review and meta-analysis

What do western blot indeterminate patterns for human immunodeficiency virus mean in eia-negative blood donors?

Prevalence of HIV Indeterminate Western Blot Tests and Follow-up of HIV Antibody Sero-Conversion in Southeastern China